GoKawiil
Tech News
Nvidia stock climbed near its all-time high of $236.54 set in May, having risen 15% over the past three months even as other AI-related stocks lagged. CoreWeave separately announced plans to deploy Nvidia's upcoming Vera Rubin chip platform in its data centers. Micron shares also rose ahead of its Wednesday evening earnings report, with investors anticipating strong results driven by tight memory supply.
Anthropic said a system of 950 AI agents spent 21 hours scanning DNA sequence databases and flagged an uncatalogued repeating pattern around a known enzyme, comparing it to the pattern that led to CRISPR. Biologists pushed back, including a biologist whose viral post was endorsed by Eli Lilly's CEO, arguing that spotting a gene cluster is far easier than determining what it actually does. A University of Copenhagen researcher who regularly used Claude said his team had already identified the same pattern, raising questions about whether Anthropic's system had drawn on his prior work.
Eli Lilly has struck a cash deal worth as much as $2.875 billion to acquire Merida Biosciences, a biotechnology company. The acquisition is aimed at strengthening Lilly's immunology drug pipeline.
Counterfeit versions of retatrutide, an experimental Eli Lilly weight-loss drug not yet submitted for FDA approval, are being sold at spas and on social media despite lacking any regulatory clearance. The drug targets three hormone receptors to suppress appetite and boost calorie burn, with early trial data suggesting significant weight loss, but no legitimate US provider is authorized to prescribe it. ABC Australia reported a case where a counterfeit vial of the drug caused severe liver damage.